JBIO (Jade Biosciences) FFO


JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $22.67
! 1 Warning Sign
View Full Analysis

What is Jade Biosciences FFO?

FFO (Funds from operations) only applies to REITs.

JBIO
12GF Score
Jade Biosciences Inc JBIO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.67
Price